Bioprinting Global Market Report 2026

Bioprinting is a cutting-edge technique that utilizes 3D-printing methods to fabricate biological structures using living cells and biomaterials. It allows for the creation of tissues or tissue-like constructs with precise and controlled architecture. This technology is designed to mimic biological functions for applications including tissue modeling, regenerative research, and experimental studies.

The main products in bioprinting include 3D bioprinters, bioinks, and 3D bioprinted products and services. 3D bioprinters are specialized machines that use layer-by-layer printing processes to build biological structures using living cells and biomaterials. Materials include living cells, hydrogels, extracellular matrices, biomaterials, and others. Technologies include inkjet bioprinting, extrusion bioprinting, laser-assisted bioprinting, magnetic levitation bioprinting, and others. Applications include tissue engineering, regenerative medicine, drug development, research, and others, with key end users including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the bioprinting market by increasing costs of imported 3d bioprinters, bioinks, and specialized biomaterials, creating challenges for manufacturers and research institutions. the tariffs particularly affect high-tech equipment segments and regions such as north america and europe that rely on imports for advanced bioprinting components. while tariffs raise production expenses, they also encourage local manufacturing, innovation in cost-effective bioinks, and domestic supply chain development, potentially driving more resilient and self-sufficient market growth.

The bioprinting market research report is one of a series of new reports from The Business Research Company that provides bioprinting market statistics, including bioprinting industry global market size, regional shares, competitors with a bioprinting market share, detailed bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the bioprinting industry. This bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioprinting market size has grown rapidly in recent years. It will grow from $2.73 billion in 2025 to $3.27 billion in 2026 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to rising demand for tissue reconstruction, increasing need for organ transplants, growing chronic disease burden, shortage of donor organs, and rising aging population.

The bioprinting market size is expected to see rapid growth in the next few years. It will grow to $6.68 billion in 2030 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine, expanding applications in drug testing and development, growing R&D investments, rising prevalence of chronic diseases, and growing interest in personalized medicine. Major trends in the forecast period include technological advancements in bioprinting hardware, innovations in bioinks and biomaterials, development of customized 3D tissue and organ models, increased use in pharmaceutical drug development and testing, and growth of public-private research collaborations in biofabrication.

The growing demand for personalized medicine is expected to drive the expansion of the bioprinting sector in the coming years. Personalized medicine is a healthcare approach that customizes treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and enhance care. This demand is rising due to advancements in genomic technologies, which allow for accurate identification of genetic variations and development of tailored treatments for patients. Bioprinting supports personalized medicine by facilitating the creation of patient-specific tissues and organ models aligned with individual biological profiles. It enhances treatment accuracy by enabling customized drug testing, regenerative therapies, and improved prediction of patient responses. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from 12 approvals in 2022. Consequently, the rising demand for personalized medicine is fueling the growth of the bioprinting sector.

Leading companies in the bioprinting sector are concentrating on creating advanced resin materials, such as polyester-based volumetric bioprinting resins, to facilitate the rapid production of complex tissue constructs with high resolution and biocompatibility. Polyester-based volumetric bioprinting resins are engineered to form complete three-dimensional structures in a single step rather than layer-by-layer, enabling the development of intricate tissue models for regenerative medicine and tissue engineering studies. For example, in May 2025, BIO INX, a Belgium-based bioink technology firm, and Readily3D, a Switzerland-based bioprinter developer, introduced READYPCL INX, a polyester-based resin that allows high-speed volumetric printing with resolutions as precise as 100 µm. The resin delivers strong mechanical performance, full biodegradability, and ISO 10993-5 biocompatibility, making it ideal for complex bone and cartilage applications. This introduction marks a notable advancement in bioprinting technology by combining speed, accuracy, and biocompatibility to support next-generation tissue engineering and regenerative medicine research.

In November 2024, Bio-INX GmbH, a Germany-based biofabrication and 3D bioprinting technology company, formed a partnership with Carl Roth GmbH + Co. KG to broaden access to 3D bioprinting solutions for life-science researchers. Through this collaboration, Bio-INX GmbH and Carl Roth GmbH + Co. KG intend to integrate Bio-INX's advanced 3D bioprinting hardware and bioinks with Carl Roth's comprehensive portfolio of cell culture reagents, biomaterials, and laboratory consumables to facilitate scalable adoption of bioprinting workflows across academic, pharmaceutical, and biotech laboratories. Carl Roth GmbH + Co. KG is a Germany-based supplier of laboratory chemicals and bioprocessing solutions.

Major companies operating in the bioprinting market are GeSiM GmbH, Poietis SAS, Stratasys Ltd., BICO Group AB, Cyfuse Biomedical K.K., Inventia Life Science Pty Ltd., Aspect Biosystems Ltd., CollPlant Biotechnologies Ltd., Pandorum Technologies Pvt. Ltd., ROKIT Healthcare Inc., Prellis Biologics Inc., 3D Systems Corporation, RegenHU Ltd., REGEMAT 3D S.L., 3DBio Therapeutics Inc., Brinter Ltd., Allevi Inc., Next Big Innovation Labs, Precise Bio Inc., TissueLabs Inc., Fluicell AB, XLife Sciences, Organovo Holdings Inc.

North America was the largest region in the bioprinting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprinting market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprinting market consists of revenues earned by entities by providing services such as custom tissue fabrication, research and development support, bioprinting design and modeling, cell and bioink optimization services, and prototyping for regenerative medicine and drug testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprinting market also includes sales of bioprinters, bioinks, living cells and biomaterials, software platforms, and bioprinting accessories and consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprinting Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioprinting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: 3D Bioprinters; Bioinks; 3D Bioprinted Products And Services
• 2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Biomaterials; Other Materials
• 3) By Technology: Inkjet Bioprinting; Extrusion Bioprinting; Laser-Assisted Bioprinting; Magnetic Levitation Bioprinting; Other Technologies
• 4) By Application: Tissue Engineering; Regenerative Medicine; Drug Development; Research; Other Applications
• 5) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End-Users
• Subsegments:
• 1) By 3D Bioprinters: Inkjet Bioprinters; Extrusion Bioprinters; Laser Assisted Bioprinters; Magnetic Levitation Bioprinters; Microvalve Bioprinters
• 2) By Bioinks: Natural Polymer Bioinks; Synthetic Polymer Bioinks; Composite Bioinks; Cell Laden Bioinks; Extracellular Matrix Based Bioinks
• 3) By 3D Bioprinted Products And Services: Bioprinted Tissue Models; Bioprinted Organ Models; Custom Bioprinting Services; Disease Modeling Products; Regenerative Medicine Constructs
• Companies Mentioned: GeSiM GmbH; Poietis SAS; Stratasys Ltd.; BICO Group AB; Cyfuse Biomedical K.K.; Inventia Life Science Pty Ltd.; Aspect Biosystems Ltd.; CollPlant Biotechnologies Ltd.; Pandorum Technologies Pvt. Ltd.; ROKIT Healthcare Inc.; Prellis Biologics Inc.; 3D Systems Corporation; RegenHU Ltd.; REGEMAT 3D S.L.; 3DBio Therapeutics Inc.; Brinter Ltd.; Allevi Inc.; Next Big Innovation Labs; Precise Bio Inc.; TissueLabs Inc.; Fluicell AB; XLife Sciences; Organovo Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.